Regeneron and ISA Pharmaceuticals Announce Strategic Immuno-Oncology Collaboration

Go back to Regeneron and ISA Pharmaceuticals Announce Strategic Immuno-Oncology Collaboration
Regeneron (NASDAQ: REGN) Delayed: 848.56 +24.74 (3.00%)
Previous Close $823.82    52 Week High $592.36 
Open $826.24    52 Week Low $325.35 
Day High $849.93    P/E 222.72 
Day Low $825.77    EPS $3.81 
Volume 326,786